Britta Weigelt Selected Research

Britta Weigelt Research Topics

Disease

125	Neoplasms (Cancer) 05/2024 - 06/2002
55	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2004
20	Carcinoma (Carcinomatosis) 11/2023 - 08/2004
18	Endometrial Neoplasms (Endometrial Cancer) 03/2024 - 05/2011
11	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 11/2017
6	Adenocarcinoma 01/2024 - 05/2011
6	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2014
5	Microsatellite Instability 02/2024 - 12/2018
5	Lobular Carcinoma 02/2024 - 07/2013
5	Triple Negative Breast Neoplasms 01/2021 - 01/2011
5	Papillary Carcinoma 01/2020 - 02/2012
4	Sarcoma (Soft Tissue Sarcoma) 12/2022 - 01/2016
4	Ductal Carcinoma 12/2014 - 11/2009
3	Disease Progression 01/2023 - 05/2011
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 01/2020
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021 - 01/2019
3	Acinar Cell Carcinoma 12/2019 - 10/2015
3	Endometrioid Carcinoma 09/2017 - 04/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 08/2021
2	Small Cell Carcinoma 10/2022 - 10/2021
2	Fibroadenoma 02/2022 - 11/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2016
2	Carcinogenesis 01/2022 - 01/2020
2	Residual Neoplasm 01/2022 - 08/2015
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 05/2014
2	Adenomyoepithelioma 01/2021 - 01/2018
2	Adenoid Cystic Carcinoma (Cylindroma) 01/2021 - 03/2010
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020 - 01/2017
2	Brain Neoplasms (Brain Tumor) 04/2018 - 05/2011
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Metaplasia 01/2017 - 03/2015
2	Lymphatic Metastasis 01/2014 - 02/2012
1	Ovarian Diseases (Ovarian Disease) 03/2024
1	Endometrial Hyperplasia 11/2023

Drug/Important Bio-Agent (IBA)

26	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2004
24	Estrogen ReceptorsIBA 01/2023 - 08/2006
16	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2014
14	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2013
13	Phenobarbital (Luminal)FDA Link 02/2017 - 08/2006
10	Hormones (Hormone)IBA 05/2024 - 07/2009
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2011
8	Trastuzumab (Herceptin)FDA Link 11/2023 - 07/2010
8	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2007
6	Cadherins (E-Cadherin)IBA 02/2024 - 11/2010
6	Lapatinib (GW572016)FDA Link 01/2023 - 07/2010
6	Formaldehyde (Formol)FDA Link 10/2019 - 01/2016
6	ParaffinIBA 10/2019 - 01/2016
5	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2020
5	MucinsIBA 01/2023 - 01/2019
4	Circulating Tumor DNAIBA 01/2023 - 10/2013
4	Cell-Free Nucleic AcidsIBA 01/2023 - 11/2017
4	AntibodiesIBA 01/2020 - 11/2010
3	CateninsIBA 11/2023 - 07/2013
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023 - 02/2022
3	Monoclonal AntibodiesIBA 10/2023 - 01/2019
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 10/2018
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2017
3	B7-H1 AntigenIBA 01/2022 - 01/2021
3	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 04/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2017 - 05/2011
3	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2014 - 01/2012
3	Messenger RNA (mRNA)IBA 06/2010 - 06/2002
3	OligonucleotidesIBA 01/2010 - 01/2007
2	Calbindin 2IBA 11/2023 - 01/2021
2	pembrolizumabIBA 10/2023 - 08/2021
2	Keratin-7 (Cytokeratin 7)IBA 01/2023 - 01/2021
2	SynaptophysinIBA 01/2023 - 02/2017
2	PlatinumIBA 11/2022 - 11/2017
2	Mediator ComplexIBA 02/2022 - 11/2015
2	MART-1 AntigenIBA 01/2022 - 01/2021
2	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 10/2021
2	human ERBB2 proteinIBA 01/2020 - 01/2017
2	Hematoxylin (Haematoxylon)IBA 01/2020 - 04/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 04/2015
2	Cyclin D1IBA 01/2020 - 11/2010
2	Codon (Codons)IBA 01/2018 - 01/2018
2	ClaudinsIBA 01/2017 - 03/2015
2	Phosphotransferases (Kinase)IBA 06/2016 - 03/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 08/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2024
1	APOBEC-1 DeaminaseIBA 05/2024
1	Peptides (Polypeptides)IBA 05/2024
1	EnzymesIBA 05/2024
1	NivolumabIBA 04/2024
1	Progesterone FDA LinkGeneric 11/2023
1	MB 3 (MB-3)IBA 11/2023
1	Estrogen Receptor alphaIBA 11/2023
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	Ado-Trastuzumab EmtansineIBA 11/2023
1	lenvatinibIBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 10/2023
1	Death Domain ReceptorsIBA 10/2023

Therapy/Procedure

48	Therapeutics 05/2024 - 06/2010
12	Drug Therapy (Chemotherapy) 01/2023 - 09/2009
5	Immunotherapy 11/2023 - 01/2021
5	Neoadjuvant Therapy 01/2023 - 08/2015
5	Radiotherapy 10/2022 - 05/2011
3	Precision Medicine 10/2017 - 01/2014
1	Ovariectomy (Oophorectomy) 03/2024